The institute stated that students who have qualified for JEE Advanced are selected for direct admission to the BS programmes ...

Hourly workers across a number of industries have long been grappling with unstable schedules and pay as their employers use ...

Want to start a career in AI? Explore the top AI jobs in India for 2026, including ML Engineer salaries, required skills like ...

Amazon One Medical has launched a GLP-1 management program that integrates primary care, pharmacy services and virtual care options to simplify the patient experience. The program aims to address ...

Amazon One Medical launched a GLP-1 program integrating obesity care with Amazon Pharmacy. Pricing for the popular weight loss drugs will begin at as low as $25 per month with insurance. Shares of ...

It is “easy to see why social media’s critics would hope for a tipping point akin to what happened with smoking,” says Sarah O’Connor. But the “story of smoking’s decline had a sting in the tail: many ...

A new Meta program is set to train fiber technicians in four weeks. Fiber optic networks are a critical link in the construction and operation of AI data centers. AI companies are sprinting to build ...

U.S. utility companies are planning to invest $1.4 trillion over the next five years to update the nation's ailing power grid as the data center boom intensifies the need for electricity. That's ...

New Google technology reduces the memory requirements of AI models. Investors were worried about slowing memory demand, but it's too early to make that call. That sparked fears among Sandisk investors ...

Streaming pitchers is not for everyone, nor is it for every week. For the most part, you're going to want to start the best ones you have, regardless of matchups. But there will be injuries. There ...

Structure Therapeutics reported highly positive Phase 2 ACCESS II data for aleniglipron, achieving ~16% placebo-adjusted weight loss with strong statistical significance and no plateau. Aleniglipron’s ...

Structure Therapeutics has touted the 16% weight loss—about 39 pounds—seen by aleniglipron as the best results yet for an oral GLP-1 drug, as the obesity biotech readies the candidate for phase 3. The ...